Biblio

Export 3141 results:
Author Title [ Type(Asc)] Year
Journal Article
A. M. Kueider, An, Y., Tanaka, T., Kitner-Triolo, M. H., Studenski, S., Ferrucci, L., and Thambisetty, M., “Sex-Dependent Associations of Serum Uric Acid with Brain Function During Aging.”, J Alzheimers Dis, vol. 60, no. 2, pp. 699-706, 2017.
J. Z. K. Caldwell, Berg, J. - L., Shan, G., Cummings, J. L., and Banks, S. J., “Sex Moderates the Impact of Diagnosis and Amyloid PET Positivity on Hippocampal Subfield Volume.”, J Alzheimers Dis, vol. 64, no. 1, pp. 79-89, 2018.
E. E. Sundermann, Edmonds, E. C., Delano-Wood, L., Galasko, D. R., Salmon, D. P., Rubin, L. H., and Bondi, M. W., “Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1163-1178, 2018.
L. Buccarello, Grignaschi, G., Castaldo, A. Maria, Di Giancamillo, A., Domeneghini, C., Melcangi, R. Cosimo, and Borsello, T., “Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1279-1292, 2017.
R. L. Cowan, Beach, P. A., Atalla, S. W., Dietrich, M. S., Bruehl, S. P., Deng, J., Wang, J., Newhouse, P. A., Gore, J. C., and Monroe, T. B., “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., “Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.”, J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
C. K. Barha, Hsiung, G. - Y. R., Best, J. R., Davis, J. C., Eng, J. J., Jacova, C., Lee, P. E., Munkacsy, M., Cheung, W., and Liu-Ambrose, T., “Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1397-1410, 2017.
A. X Alvarez, Alvarez, I., Aleixandre, M., Linares, C., Muresanu, D., Winter, S., and Moessler, H., “Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1003-1013, 2018.
M. Defrancesco, Marksteiner, J., Kemmler, G., Fleischhacker, W. Wolfgang, Blasko, I., and Deisenhammer, E. A., “Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1439-1448, 2017.
J. Yuan, Maserejian, N., Liu, Y., Devine, S., Gillis, C., Massaro, J., and Au, R., “Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., “Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.”, J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.
R. Palm, Sorg, C. G. G., Ströbel, A., Gerritsen, D. L., and Holle, B., “Severe Agitation in Dementia: An Explorative Secondary Data Analysis on the Prevalence and Associated Factors in Nursing Home Residents.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1463-1470, 2018.
L. - L. Li, Ma, Y. - H., Bi, Y. - L., Sun, F. - R., Hu, H., Hou, X. - H., Xu, W., Shen, X. - N., Dong, Q., Tan, L., Yang, J. - L., and Yu, J. - T., “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
K. Amy Lin, Rundel, C., and P Doraiswamy, M., “Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1123-1130, 2017.
L. Rozzini, Lanfranchi, F., Pilotto, A., Catalani, S., Gilberti, M. Enrica, Paganelli, M., Apostoli, P., and Padovani, A., “Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.”, J Alzheimers Dis, vol. 61, no. 3, pp. 907-912, 2018.
P. Kundu, Zimmerman, B., Quinn, J. F., Kaye, J., Mattek, N., Westaway, S. K., and Raber, J., “Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1471-1481, 2022.
J. A. Zegarra-Valdivia, Santi, A., de Sevilla, M. Estrella F., Nuñez, A., and Aleman, I. Torres, “Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities.”, J Alzheimers Dis, vol. 69, no. 4, pp. 979-987, 2019.
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
R. Zanardini, Benussi, L., Fostinelli, S., Saraceno, C., Ciani, M., Borroni, B., Padovani, A., Binetti, G., and Ghidoni, R., “Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1053-1060, 2018.
R. Squitti, Fostinelli, S., Siotto, M., Ferrari, C., Binetti, G., Benussi, L., Rongioletti, M., and Ghidoni, R., “Serum Copper is not Altered in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1427-1432, 2018.
A. M. V. Wennberg, Gustafson, D., Hagen, C. E., Roberts, R. O., Knopman, D., Jack, C., Petersen, R. C., and Mielke, M. M., “Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 53, no. 2, pp. 573-81, 2016.
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., “Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.”, J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., “Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators.”, J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.

Pages